| IPO Company Profile © ipodata.com |
| Message Board | SEC Filings | Peer IPO Companies |
| Digirad Corporation |
| 9350 Trade Place, San Diego, CA 92126 * (858) 578-5300 |
| Business Description | The company is the first and only company to have developed and commercialized a solid-state, digital gamma camera for use in nuclear medicine. |
|
Filing Information IPO has been | |||
| To Trade As | DRAD (NASNTL) | Industry | Manufacturing (SIC 3845) |
| Type of Stock Offered | Common Shares | Filing Date | 8/24/2001 |
| Domestic Shares Filed | 0 | Filing Price | - - |
| Foreign Shares Filed | 0 | Offering Amount | $60,000,000 |
| Company Shares | 0 | Est. Expenses | - - |
| Selling Shrhldrs Shares | 0 | Post-IPO Shares | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| UBS Warburg LLC | Lead Manager | |
| First Union Capital Markets Corp. | Co-manager | (804) 649-2311 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1998 | 12/31/1999 | 12/31/2000 | 6/30/2000 | 6/30/2001 | ||
| Revenues | - | - | 1.921 | 0.284 | 7.075 | 1.456 | 14.019 |
| Income from Oper. | - | - | -7.049 | -13.466 | -12.939 | -5.595 | -5.445 |
| Net Income | - | - | -6.192 | -13.192 | -13.476 | -5.692 | -5.846 |
| E.P.S | - | - | -1.870 | -3.900 | -3.610 | -1.650 | -1.350 |
| Revenue Growth (%) | - | - | -85.22 | 2,391.197 | 862.84 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | - | - |
| Net Profit Margin (%) | - | - | - | - | - | - | - |
| Cash Flow - Oper. | -15.02 | -9.09 | -9.13 | ||||
| Cash Flow - Inv. | -7.24 | -0.89 | -2.52 | ||||
| Cash Flow - Fin. | 26.19 | 11.30 | 8.60 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/2001 | Financial Ratios | ||||
| Total Assets | 28.56 | Current Assets | 17.25 | Current Ratio | 1.35 |
| Total Liab. | 76.67 | Current Liab. | 12.75 | Debt Ratio | 268.47% |
| Total Equity | -48.11 | Working Cap. | 4.50 | Debt to Equity Ratio | - |
| Cash | 3.51 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for repayment of outstanding debt and general corporate purposes including product development, marketing, capital expenditures and working capital. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Brobeck, Phleger & Harrison |
| Bank's Law Firm | Alston & Bird |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Entities affiliated with Kingsbury Associates | 19.20 | |
| Entities affiliated with Vector Fund Management | 14.90 | |
| Entities affiliated with Sorrento Associates | 13.10 | |
| Entities affiliated with Merrill Lynch Venutres | 6.50 | |
| Note: represents ownership of 5% or more prior to the offering. | ||